Welcome to CMEZone

CMEZone.com is a full-service web solution that provides timely, practical, and clinically relevant continuing education for health care professionals. All CMEZone activities are designed to enhance clinical knowledge and competence and to improve patient care.

More than 100,000 health care professionals maintain membership in CMEZone in order to access continuing education activities on demand. All activities are easily accessible, free of charge and offer participants instantaneous post-test grading and printable certificates of completion.

CMEZone is operated by Applied Clinical Education (ACE). As an advocate of lifelong learning and supporter of applied learning strategies, ACE is dedicated to providing education that strengthens performance and enhances the clinical care of patients.

Participant Login


Remember Me
Lost your password? New user? Register here
Chronic Lymphocytic Leukemia: Updates and Important Unanswered Questions
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
Breast Cancer: ASCO 2015 Review
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
Lung Cancer
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
B-Cell Non-Hodgkin Lymphomas
Credits: 0.5 Accreditation: ACCME
Expires: October 13, 2016
Credits: 1 Accreditation: ACCME
Expires: October 18, 2016
Gynecologic Oncology
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Hodgkin Lymphoma & Lymphoplasmacytic Lymphoma
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Multiple Myeloma & Evolving Role of Transplant
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Colorectal Cancer
Credits: 0.5 Accreditation: ACCME
Expires: November 4, 2016
Credits: 1.25 Accreditation: ACCME
Expires: December 1, 2016
Credits: 1 Accreditation: ACCME
Expires: June 1, 2017
Credits: 1 Accreditation: ACCME
Expires: January 13, 2017
Credits: 1 Accreditation: ACCME
Expires: January 16, 2017
Credits: 1 Accreditation: ACCME
Expires: March 8, 2017
Part 1: Screening and Diagnosis
Credits: 0.75 Accreditation: ACCME
Expires: June 7, 2017
Part 2: Driver Mutations in Adenocarcinoma
Credits: 0.5 Accreditation: ACCME
Expires: June 7, 2017
Part 3: Squamous Cell Disease
Credits: 0.5 Accreditation: ACCME
Expires: June 7, 2017
Credits: 1 Accreditation: ACCME
Expires: February 16, 2017
Credits: 1 Accreditation: CCM
Expires: April 29, 2017
Credits: 1 Accreditation: ACCME
Expires: January 7, 2017

The perception that aspirin raises the risk for deadly gastrointestinal bleeding appears to be a bad rap, a new study suggests. Approved as a blood-based companion diagnostic for osimertinib (Tagrisso, AstraZeneca) to provide an alternative way of identifying non-small cell lung cancer (... A lack of sleep can be cured by a co-fellow's advice or a patient's smile. Currently in Phase III clinical trials, glecaprevir/pibrentasvir is an investigational, pan-genotypic regimen being evaluated for the treatment of chronic H... The prevalence of illicit drug use among adults with chronic low back pain in the United States was much greater than among those without such pain, according t... Currently in Phase III clinical trials, glecaprevir/pibrentasvir is an investigational, pan-genotypic regimen being evaluated for the treatment of chronic HCV g... Over the past 15 years editorializing for General Surgery News, I have opined on several occasions about dress codes for surgeons both in and out of the operati...